Australia has secured another two agreements to access potential COVID-19 vaccines early next year.
Australia will get 135 million doses of four different potential vaccines at a cost of $ 3.2 billion
The four are the University of Queensland and CSL vaccines, the University of Oxford and AstraZeneca candidates, and now 40 million doses from Novavax, and 10 million from Pfizer.
Regardless of which vaccine works, the federal government says health workers, the vulnerable elderly in Australia will be immunized first and for free.
Listen to SBS Indonesian every Monday, Wednesday, Friday and Sunday at 3 pm. Follow us on Facebook and catch us on podcasts.
Share
